Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S O Ogren

Showing results (141-150 of 257) with videos related to

Pageof 26
Sort By:
Molecular Psychiatry|July 9, 2004
Influenza A virus infection causes alterations in expression of synaptic regulatory genes combined with changes in cognitive and emotional behaviors in miceS Beraki, F Aronsson, H Karlsson, et al.
Pharmacology & Toxicology|March 1, 1987
Differential effects of the dopamine antagonist remoxipride on apomorphine induced behaviour in the ratL Ståhle, T Ljungberg, A Rodebjer, et al.
Neuroscience Letters|February 28, 1985
The putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin antagonizes the antinociceptive effect of morphineO G Berge, O B Fasmer, S O Ogren, et al.
Journal of Medicinal Chemistry|January 1, 1978
Selective monoamine oxidase inhibitors. 1. Compounds related to 4-aminophenethylamineL Florvall, A L Ask, S O Ogren, et al.
Acta Physiologica Scandinavica|August 1, 1989
Increased levels of substance P and cholecystokinin in rat cerebral cortex following repeated electroconvulsive shock and subchronic treatment with a serotonin uptake inhibitorK Brodin, A Rosén, K Iwarsson, et al.
Neuropharmacology|March 8, 2003
Activation of 5-HT(1A) autoreceptors enhances the inhibitory effect of galanin on hippocampal 5-HT release in vivoT Yoshitake, S Yoshitake, M Yamaguchi, et al.
Journal of Neural Transmission|January 1, 1984
Alaproclate, a new selective 5-HT uptake inhibitor with therapeutic potential in depression and senile dementiaS O Ogren, A C Holm, H Hall, et al.
Arzneimittel-Forschung|January 1, 1985
[Selective antidopaminergic properties of remoxiprid, a new potential antipsychotic agent]S O Ogren, H Hall, C Köhler, et al.
Acta Pharmacologica Et Toxicologica|January 1, 1985
Effects of antidepressant drugs on cerebral serotonin receptor mechanismsS O Ogren, K Fuxe, L F Agnati, et al.
Toxicology Letters|November 1, 1992
Ganglioside GM1 counteracts the enhancing effects of subacute toluene exposure on apomorphine-induced locomotor activityG von Euler, S O Ogren, K Fuxe, et al.
Pageof 26

Showing results (141-150 of 257) with videos related to

Sort By:
Pageof 26
Molecular Psychiatry|July 9, 2004
Influenza A virus infection causes alterations in expression of synaptic regulatory genes combined with changes in cognitive and emotional behaviors in miceS Beraki, F Aronsson, H Karlsson, et al.
Pharmacology & Toxicology|March 1, 1987
Differential effects of the dopamine antagonist remoxipride on apomorphine induced behaviour in the ratL Ståhle, T Ljungberg, A Rodebjer, et al.
Neuroscience Letters|February 28, 1985
The putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin antagonizes the antinociceptive effect of morphineO G Berge, O B Fasmer, S O Ogren, et al.
Journal of Medicinal Chemistry|January 1, 1978
Selective monoamine oxidase inhibitors. 1. Compounds related to 4-aminophenethylamineL Florvall, A L Ask, S O Ogren, et al.
Acta Physiologica Scandinavica|August 1, 1989
Increased levels of substance P and cholecystokinin in rat cerebral cortex following repeated electroconvulsive shock and subchronic treatment with a serotonin uptake inhibitorK Brodin, A Rosén, K Iwarsson, et al.
Neuropharmacology|March 8, 2003
Activation of 5-HT(1A) autoreceptors enhances the inhibitory effect of galanin on hippocampal 5-HT release in vivoT Yoshitake, S Yoshitake, M Yamaguchi, et al.
Journal of Neural Transmission|January 1, 1984
Alaproclate, a new selective 5-HT uptake inhibitor with therapeutic potential in depression and senile dementiaS O Ogren, A C Holm, H Hall, et al.
Arzneimittel-Forschung|January 1, 1985
[Selective antidopaminergic properties of remoxiprid, a new potential antipsychotic agent]S O Ogren, H Hall, C Köhler, et al.
Acta Pharmacologica Et Toxicologica|January 1, 1985
Effects of antidepressant drugs on cerebral serotonin receptor mechanismsS O Ogren, K Fuxe, L F Agnati, et al.
Toxicology Letters|November 1, 1992
Ganglioside GM1 counteracts the enhancing effects of subacute toluene exposure on apomorphine-induced locomotor activityG von Euler, S O Ogren, K Fuxe, et al.
Pageof 26